Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Benefits Costs topic
No spam. Unsubscribe anytime.
County hears health‑plan briefing as GLP‑1 drugs drive pharmacy costs; consultants propose direct‑provider contracts and weight‑management program
Summary
Consultants reported year‑to‑date plan costs of about $10.1M (medical ~$6.59M, pharmacy ~$2.7M). They said six GLP‑1 drugs account for roughly 48% of pharmacy costs and proposed RFPs for direct provider contracts, urgent‑care agreements and a weight‑management program to reduce spend.
County consultants presented a detailed review of the employee health plan, reporting year‑to‑date medical claims of about $6,589,468 and pharmacy claims of about $2,700,000, with a total plan cost of approximately $10,103,994.
"As of January 2026, your medical claims are at 6,589,468, pharmacies at 2,700,000," consultant Javier Leon told the court, and noted nine high‑cost claimants and a stop‑loss exposure of roughly $813,000. Leon identified six GLP‑1 drugs as driving about 48% of pharmacy spend and said the county has 103 current utilizers of the widely used GLP‑1 medication Wegovy accounting for roughly $365,000 of pharmacy spend.
The consultants recommended pursuing direct provider contracts with local primary‑care and urgent‑care providers and negotiating discounts for services; they also proposed a structured weight‑management program with physician oversight so GLP‑1 use would be paired with lifestyle and clinical management. Leon described the potential to save plan dollars by steering members to lower‑cost mail‑order or approved direct programs and by reducing avoidable emergency‑room utilization.
Commissioners asked for implementation details and cost scenarios; the court authorized staff and consultants to pursue the recommended procurement steps and to return with concrete proposals for contract terms and expected savings. The court voted to move forward with the recommendations as a direction to staff rather than an immediate binding contract award.
